antigen-displaying lipid-enveloped plga nanoparticles as delivery agents for a plasmodium vivax malaria vaccineantigen-displaying lipid-enveloped plga纳米粒作为间日疟原虫疟疾疫苗交付代理.pdfVIP

antigen-displaying lipid-enveloped plga nanoparticles as delivery agents for a plasmodium vivax malaria vaccineantigen-displaying lipid-enveloped plga纳米粒作为间日疟原虫疟疾疫苗交付代理.pdf

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
antigen-displaying lipid-enveloped plga nanoparticles as delivery agents for a plasmodium vivax malaria vaccineantigen-displaying lipid-enveloped plga纳米粒作为间日疟原虫疟疾疫苗交付代理

Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine 1,2 1,2,6 3 3 3 James J. Moon , Heikyung Suh , Mark E. Polhemus , Christian F. Ockenhouse , Anjali Yadava , Darrell J. Irvine1,2,4,5,6* 1 Department of Materials Science and Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, United States of America, 2 Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, United States of America, 3 Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America, 4 Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, United States of America, 5 Ragon Institute of MGH, MIT, and Harvard, Boston, Massachusetts, United States of America, 6 Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America Abstract The parasite Plasmodium vivax is the most frequent cause of malaria outside of sub-Saharan Africa, but efforts to develop viable vaccines against P. vivax so far have been inadequate. We recently developed pathogen-mimicking polymeric vaccine nanoparticles composed of the FDA-approved biodegradable polymer poly(lactide-co-glycolide) acid (PLGA) ‘‘enveloped’’ by a lipid membrane. In this study, we sought to determine whether this vaccine delivery platform could be applied to enhance the immune response against P. vivax sporozoites. A candidate malaria antigen, VMP001, was conjugated to the lipid membrane of the particles, and an immunostimulatory molecule, monophosphoryl lipid A (MPLA), was incorporated into the lipid membranes, creating pathogen-mimicking na

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档